LEADER 01319nam2-2200409---450 
001 996551568403316
005 20240116115750.0
010   $a978-012-8206676
035   $a000609319
035   $aUSA01000609319
035   $a(ALEPH)000609319USA01
035   $a000609319
100   $a20090918h2020----km-y0itay50------ba
101   $aeng
102   $aUS
105   $aaf--||||001yy
200 1 $aTumor immunology and immunotherapy$eintegrated methods Part B$fedited by Lorenzo Galluzzi and Nild-Petter Rudquist
210   $aCambridge [MA]$cAcademic Press$d2020
215   $a406 p.$cill.$d24 cm
225 2 $aMethods in enzymology$v636
410  0$1001990002876030203316$12001$aMethods in enzymology$v636
606 0 $aTumori$xImmunoterapia$2BNCF
676   $a615.37
702  1$aGALLUZZI,$bLorenzo
702  1$aRUDQUIST,$bNils-Petter
801  0$aIT$bsalbc$gISBD
912   $a996551568403316
951   $a572.7 MET/636$b6456 Farm.$c572$d544454
959   $aBK
969   $aFAR
979   $aPAOLA$b90$c20151028$lUSA01$h1542
979   $aPAOLA$b90$c20151028$lUSA01$h1543
979   $aPAOLA$b90$c20151028$lUSA01$h1545
979   $aPAOLA$b90$c20151028$lUSA01$h1621
979   $aPAOLA$b90$c20151221$lUSA01$h1640
996   $aTumor Immunology and Immunotherapy$91568163
997   $aUNISA